Log In
BCIQ
Print this Print this
 

Trusopt, dorzolamide

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionTopical carbonic anhydrase inhibitor
Molecular Target
Mechanism of ActionCarbonic anhydrase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$700.0M

$600.0M

$100.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/03/2015

Undisclosed

Undisclosed

Undisclosed

05/13/2014

$700.0M

$600.0M

$100.0M

Get a free BioCentury trial today